Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA4 | P22748 | 3/20 | 0.36 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glyoxylate SCHEMBL94446 | 0.91 | CA1 (0.36) | CA1CA4FAHD1CA9 | |
| Glyoxylate SCHEMBL11209424 | 0.91 | CA1 (0.36) | CA1CA4FAHD1CA9 | |
| Glyoxylate SCHEMBL3031126 | 0.91 | CA1 (0.36) | CA1CA4FAHD1CA9 | |
| Glyoxylate SCHEMBL3588289 | 0.91 | CA1 (0.36) | CA1CA4FAHD1CA9 | |
| Glyoxylate SCHEMBL314561 | 0.91 | CA1 (0.36) | CA1CA4FAHD1CA9 | |
| Glyoxylate SCHEMBL5357985 | 0.91 | CA1 (0.36) | CA1CA4FAHD1CA9 | |
| Glyoxylate SCHEMBL3704926 | 0.91 | CA1 (0.36) | CA1CA4FAHD1CA9 | |
| Glyoxylate SCHEMBL2495812 | 0.91 | CA1 (0.36) | CA1CA4FAHD1CA9 | |
| Glyoxylate SCHEMBL3593610 | 0.91 | CA1 (0.36) | CA1CA4FAHD1CA9 | |
| Glyoxylate SCHEMBL3596612 | 0.91 | CA1 (0.36) | CA1CA4FAHD1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021195540-A1 | CANNABINOID BASED COMPOSITION FOR MITIGATION OF VIRAL EFFECTS | RADIENT TECHNOLOGIES INNOVATIONS INC. (CA) | 2021-09-30 | — | — | WO | claimed |
| WO-2010009275-A1 | METHODS OF TREATING INFLAMMATION | INTEGRITAS PHARMA, INC (US) | 2010-01-21 | — | — | WO | claimed |
| EP-1416926-A4 | ZINC CONTAINING COMPOSITIONS FOR ANTI-VIRAL USE | SMITH JEFFREY B (US) | 2009-03-04 | — | — | EP | claimed |
| US-7462369-B2 | Anti-viral compositions and methods of making and using the anti-viral compositions | Smith, Jeffrey B. (US) | 2008-12-09 | — | — | US | claimed |
| US-20080274209-A1 | METHODS OF TREATING INFLAMMATION | INTEGRITAS PHARMA, INC. | 2008-11-06 | — | — | US | claimed |
| US-6855341-B2 | Anti-viral compositions and methods of making and using the anti-viral compositions | SMITH JEFFREY B (US) | 2005-02-15 | — | — | US | claimed |
| US-20050003020-A1 | Anti-viral compositions and methods of making and using the anti-viral compositions | SMITH JEFFREY B (US) | 2005-01-06 | — | — | US | claimed |
| EP-1416926-A2 | ZINC CONTAINING COMPOSITIONS FOR ANTI-VIRAL USE | Smith, Jeffrey B. (US) | 2004-05-12 | — | — | EP | claimed |
| US-20040086575-A1 | Anti-viral compositions and methods of making and using the anti-viral compositions | SMITH JEFFREY B (US) | 2004-05-06 | — | — | US | claimed |
| US-6730329-B1 | TREATING LESIONOUS SYMPTOMS TOPICALLY WITH ACTIVE MATERIAL SALT AND ANTIOXIDANT | SMITH JEFFREY B (US) | 2004-05-04 | — | — | US | claimed |
| WO-2002098339-A2 | ZINC CONTAINING COMPOSITIONS FOR ANTI-VIRAL USE | SMITH JEFFREY B (US) | 2002-12-12 | — | — | WO | claimed |
| US-6475526-B1 | Zinc containing compositions for anti-viral use | SMITH JEFFREY B (US) | 2002-11-05 | — | — | US | claimed |
| EP-0761806-B1 | Polyurea-thickened grease composition | LUBRIZOL CORP (US) | 2001-10-31 | — | — | EP | claimed |
| US-6214778-B1 | OILS AND LUBRICANTS WITH THICKENERS AND ZINC OVERBASED SALTS | THE LUBRIZOL CORPORATION | 2001-04-10 | — | — | US | claimed |
| EP-0761806-A1 | Polyurea-thickened grease composition | The Lubrizol Corporation (US) | 1997-03-12 | — | — | EP | claimed |
| US-4407818-A | HERPES SIMPLEX VIRUS | BIO-SYSTEMS RESEARCH, INC. (US) | 1983-10-04 | — | — | US | claimed |
| JP-9104889-A | — | — | None | — | — | JP | disclosed |
| CN-110650944-B | Silica-based zinc catalysts, their preparation and use in the alkoxycarbonylation of amines | 科思创德国股份有限公司 | 2022-07-19 | — | — | CN | disclosed |
| EP-0049671-A1 | New metal oxyalkylates, pharmaceutical compositions containing the same and process for preparing the same | BioSystems Research, Inc. (US) | 1982-04-14 | — | — | EP | disclosed |
| US-4268683-A | ZIN OR TIN COMPOUNDS AS ACID CATALYSTS | THE DOW CHEMICAL COMPANY (US) | 1981-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080274209-A1 | METHODS OF TREATING INFLAMMATION | MPO, SOD1, MMP8 | CA1 2983/4885CA4 1891/4885FAHD1 2709/4885 |
| US-20040086575-A1 | Anti-viral compositions and methods of making and using the anti-viral compositions | ZC3HAV1, ZC3HAV1L, SOD3 | CA1 2436/4885CA4 1492/4885FAHD1 1350/4885 |
| US-20050003020-A1 | Anti-viral compositions and methods of making and using the anti-viral compositions | ZC3HAV1, ZC3HAV1L, SOD3 | CA1 2436/4885CA4 1492/4885FAHD1 1350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.